Scynexis SCYX
NASDAQ SCYX
$5.19 +0.04 (+0.78%)
As of: Aug 20, 2026 · 3:59 PM EDT

Scynexis (SCYX) Other Non-Current Liabilities (2013 - 2026)

Scynexis' (SCYX) quarterly Other Non-Current Liabilities came in at $18.9 million in Q1 2026, up 270.59% YoY from $5.1 million in Q1 2025, and up 759.09% on a QoQ basis from $2.2 million in Q4 2025.

Scynexis (SCYX) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has 13 years of Other Non-Current Liabilities data on file, last reported at $18.9 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 270.59% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (up 270.59% YoY) and the FY2025 annual result came in at $2.2 million, down 72.5% from the prior year.
  • Other Non-Current Liabilities grew to $18.9 million in Q1 2026, from $2.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $40.3 million in Q1 2023 to a low of $2.2 million in Q4 2025.
  • A 5-year average of $15.2 million and a median of $12.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 5557.86% — and 2025, when it plunged 83.89%.
  • Tracing SCYX's Other Non-Current Liabilities over 5 years: stood at $18.6 million in 2022, then increased by 16.56% to $21.7 million in 2023, then tumbled by 63.1% to $8.0 million in 2024, then plunged by 72.5% to $2.2 million in 2025, then jumped by 759.09% to $18.9 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $18.9 million (Q1 2026), $2.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Scynexis 61.37 Mn -53.33 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 800,000.00
Mar 31, 2026 18.90 Mn
Dec 31, 2025 2.20 Mn
Sep 30, 2025 3.54 Mn
Jun 30, 2025 2.90 Mn
Mar 31, 2025 5.10 Mn
Dec 31, 2024 8.00 Mn
Sep 30, 2024 11.21 Mn
Jun 30, 2024 18.00 Mn
Mar 31, 2024 12.20 Mn
Dec 31, 2023 21.68 Mn
Sep 30, 2023 24.60 Mn
Jun 30, 2023 30.09 Mn
Mar 31, 2023 40.32 Mn
Dec 31, 2022 18.60 Mn
Sep 30, 2022 27.73 Mn
Jun 30, 2022 5.06 Mn
Mar 31, 2022 7.92 Mn
Dec 31, 2021 3.35 Mn
Sep 30, 2021 2.10 Mn